HOME >> BIOLOGY >> NEWS
IUPAC, IUPHAR, And IUTOX Publish A Report On Natural And Anthropogenic Environmental Oestrogens: The Scientific Basis For Risk Assessment

The scientific underpinning for the controversial international concerns about endocrine disrupters has been addressed in detail in a recent issue of the journal Pure and Applied Chemistry (ref. Vol. 70, No. 9, 1998). This effort by three preeminent international scientific organizations covers a wide range of scientific aspects and subjects relevant to the issue and provides the background information necessary for informed debate.

The 19-chapter report, "Natural and Anthropogenic Environmental Oestrogens: The Scientific Basis for Risk Assessment" was prepared by the International Union of Pure and Applied Chemistry (IUPAC) in collaboration with the International Unions of Pharmacology (IUPHAR) and of Toxicology (IUTOX), and with the support of the International Council for Science (ICSU). The subject, commonly known as endocrine or hormone disrupters, is a complex, emotional, and controversial issue for which many scientific questions remain. Several aspects related to human and environmental health are presented, and the Conclusions and Recommendations drafted by the presidents of the three Unions review the policy issues and how they relate to the science.

This publication is the result of continuous efforts to address issues of societal and industrial concern objectively, involving the chemical sciences. A similar report on Chlorine was published in September 1996.


'"/>

Contact: IUPAC Secretariat
secretariat@iupac.org
1-919-485-8700
International Union of Pure and Applied Chemistry
5-May-1999


Page: 1

Related biology news :

1. Published research contains high level of statistical errors
2. NYAS and Nature Publishing Group join forces
3. Mosquito genome sequence--Published in the journal Science
4. Breakthrough On Microbial Disease Published In Science
5. 14,000 Years Of Atmospheric Lead Emissions Recorded In Swiss Peat Bog As Published In Science Magazine
6. University of Georgia Genetics Professor John Avise Publishes The Genetic Gods, A New Book On Evolution And Belief
7. Report outlines vision and recommendations for microbiology in the 21st Century
8. Report outlines steps needed to lessen smallpox threat
9. Reporters from Science Magazine to receive ASM Public Communications Award
10. Report in BioScience details global decline of nonmarine mollusks
11. National Academies news: Report on EPAs particulate matter research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... Research and Markets has announced the addition of the "Biometric ... to their offering. ... The biometric vehicle access system market, in terms of value, ... to 2021. The market is estimated to be USD 442.7 Million ... The growth of the biometric vehicle access system market is fueled ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... ... January 12, 2017 , ... After her brain cancer ... gave her only a few months to live. Now a paper publishing January ... Rosendahl’s disease and increased both the quantity and quality of her life: Adding ...
(Date:1/12/2017)... and Pune, India , January 12, 2017 ... Market by Type and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," ... 2022 from $2,921 million in 2015, growing at a CAGR of 15.07% during the ... ... Allied Market Research Logo ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical trial ... of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The ... percent of these heavily pretreated patients saw clinical benefit from the drug, with ...
(Date:1/11/2017)... ... January 11, 2017 , ... Photonics industry and STEM ... are commending the U.S. Congress and President Obama for their recognition of the ... the American Innovation and Competitiveness Act (AICA). , The language of the act ...
Breaking Biology Technology:
Cached News: